Cargando…
Answering the Big Clinical Questions in Brain Metastasis Management
Management of brain metastases is challenging, both because of the historically guarded prognosis and evolving, more efficacious treatment paradigms for metastatic cancer. This perspective addresses several of the important difficult questions that practitioners treating patients with brain tumors f...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805701/ https://www.ncbi.nlm.nih.gov/pubmed/35118002 http://dx.doi.org/10.3389/fonc.2021.834122 |
_version_ | 1784643283491749888 |
---|---|
author | Kirkpatrick, John P. |
author_facet | Kirkpatrick, John P. |
author_sort | Kirkpatrick, John P. |
collection | PubMed |
description | Management of brain metastases is challenging, both because of the historically guarded prognosis and evolving, more efficacious treatment paradigms for metastatic cancer. This perspective addresses several of the important difficult questions that practitioners treating patients with brain tumors face in the clinic. Successfully answering these questions requires knowledge of the clinical evidence, thoughtful discussion of the patient’s goals of care and collaboration in a multi-disciplinary setting. |
format | Online Article Text |
id | pubmed-8805701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88057012022-02-02 Answering the Big Clinical Questions in Brain Metastasis Management Kirkpatrick, John P. Front Oncol Oncology Management of brain metastases is challenging, both because of the historically guarded prognosis and evolving, more efficacious treatment paradigms for metastatic cancer. This perspective addresses several of the important difficult questions that practitioners treating patients with brain tumors face in the clinic. Successfully answering these questions requires knowledge of the clinical evidence, thoughtful discussion of the patient’s goals of care and collaboration in a multi-disciplinary setting. Frontiers Media S.A. 2022-01-18 /pmc/articles/PMC8805701/ /pubmed/35118002 http://dx.doi.org/10.3389/fonc.2021.834122 Text en Copyright © 2022 Kirkpatrick https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Kirkpatrick, John P. Answering the Big Clinical Questions in Brain Metastasis Management |
title | Answering the Big Clinical Questions in Brain Metastasis Management |
title_full | Answering the Big Clinical Questions in Brain Metastasis Management |
title_fullStr | Answering the Big Clinical Questions in Brain Metastasis Management |
title_full_unstemmed | Answering the Big Clinical Questions in Brain Metastasis Management |
title_short | Answering the Big Clinical Questions in Brain Metastasis Management |
title_sort | answering the big clinical questions in brain metastasis management |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805701/ https://www.ncbi.nlm.nih.gov/pubmed/35118002 http://dx.doi.org/10.3389/fonc.2021.834122 |
work_keys_str_mv | AT kirkpatrickjohnp answeringthebigclinicalquestionsinbrainmetastasismanagement |